Coherus BioSciences
Price & Volume
Stats
See more52W Range | $0.80-$2.61 |
Market Cap | $138.8M |
Shares Short | 12M |
Financials
See moreRevenue (12 Mos) | $50.9M |
Revenue Growth (YoY) | 39.5% |
Gross Profit (12 Mos) | $35.1M |
Diluted EPS | -$1.25 |
News
See moreYahoo Finance • 4 months ago
Coherus and Zumutor Biologics Announce Clinical Collaboration to Evaluate ZM008 in Combination with LOQTORZI® (toripalimab-tpzi)
Yahoo Finance • 6 months ago
Here Are Monday’s Top Wall Street Analyst Research Calls: Dell Technologies, BioMarin Pharmaceutical, Disney, HubSpot, Klarna, Oklo, Pitney Bowes, Trade Desk, Wendy’s, and More
Yahoo Finance • 8 months ago
Coherus outlines $175M annualized LOQTORZI target by 2028 as commercial expansion accelerates
Yahoo Finance • 8 months ago
Coherus BioSciences Q4 2025 Earnings Preview
About
CEO | Mr. Dennis M. Lanfear |
Address | 333 Twin Dolphin Drive, Redwood City, CA, United States, 94065 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 144 |